NLTX Annual Total Long Term Liabilities
$10.55 M
-$1.21 M-10.27%
31 December 2022
Summary:
As of January 21, 2025, NLTX annual total long term liabilities is $10.55 million, with the most recent change of -$1.21 million (-10.27%) on December 31, 2022. During the last 3 years, it has risen by +$9.96 million (+1679.93%).NLTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly Long Term Liabilities
$9.14 M
-$410.00 K-4.29%
30 September 2023
Summary:
As of January 21, 2025, NLTX quarterly total long term liabilities is $9.14 million, with the most recent change of -$410.00 thousand (-4.29%) on September 30, 2023. Over the past year, it has dropped by -$1.55 million (-14.52%).NLTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.3% | -14.5% |
| 3 y3 years | +1679.9% | -20.2% |
| 5 y5 years | +2071.8% | +2564.4% |
NLTX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -86.6% | -88.4% |
Neoleukin Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $9.14 M(-4.3%) |
| June 2023 | - | $9.55 M(-4.0%) |
| Mar 2023 | - | $9.95 M(-5.8%) |
| Dec 2022 | $10.55 M(-10.3%) | $10.55 M(-1.3%) |
| Sept 2022 | - | $10.69 M(-3.2%) |
| June 2022 | - | $11.04 M(-3.5%) |
| Mar 2022 | - | $11.44 M(-2.8%) |
| Dec 2021 | $11.76 M(+3.1%) | $11.76 M(-2.6%) |
| Sept 2021 | - | $12.07 M(-2.4%) |
| June 2021 | - | $12.37 M(-2.8%) |
| Mar 2021 | - | $12.73 M(+11.5%) |
| Dec 2020 | $11.41 M(+1824.8%) | $11.41 M(-0.4%) |
| Sept 2020 | - | $11.46 M(+11.2%) |
| June 2020 | - | $10.30 M(-0.2%) |
| Mar 2020 | - | $10.33 M(+1641.7%) |
| Dec 2019 | $593.00 K(+85.9%) | $593.00 K(+68.9%) |
| Sept 2019 | - | $351.00 K(+37.6%) |
| June 2019 | - | $255.00 K(-13.9%) |
| Mar 2019 | - | $296.00 K(-7.2%) |
| Dec 2018 | $319.00 K | $319.00 K(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $343.00 K(-14.5%) |
| June 2018 | - | $401.00 K(-9.5%) |
| Mar 2018 | - | $443.00 K(-8.8%) |
| Dec 2017 | $486.00 K(+146.7%) | $486.00 K(-5.3%) |
| Sept 2017 | - | $513.00 K(-6.4%) |
| June 2017 | - | $548.00 K(-2.5%) |
| Mar 2017 | - | $562.00 K(+185.3%) |
| Dec 2016 | $197.00 K(+50.4%) | $197.00 K(+38.7%) |
| Sept 2016 | - | $142.00 K(+24.6%) |
| June 2016 | - | $114.00 K(+7.5%) |
| Mar 2016 | - | $106.00 K(-19.1%) |
| Dec 2015 | $131.00 K(+81.9%) | $131.00 K(-7.7%) |
| Sept 2015 | - | $142.00 K(+115.2%) |
| June 2015 | - | $66.00 K(-16.5%) |
| Mar 2015 | - | $79.00 K(+9.7%) |
| Dec 2014 | $72.00 K(-99.9%) | $72.00 K(+13.0%) |
| Sept 2014 | - | $63.70 K(-31.6%) |
| June 2014 | - | $93.10 K(-18.8%) |
| Mar 2014 | - | $114.60 K(-99.9%) |
| Dec 2013 | $78.72 M(+48.4%) | $78.72 M |
| Dec 2012 | $53.06 M | - |
FAQ
- What is Neoleukin Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual total long term liabilities year-on-year change?
- What is Neoleukin Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly long term liabilities year-on-year change?
What is Neoleukin Therapeutics annual total long term liabilities?
The current annual total long term liabilities of NLTX is $10.55 M
What is the all time high annual total long term liabilities for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual total long term liabilities is $78.72 M
What is Neoleukin Therapeutics annual total long term liabilities year-on-year change?
Over the past year, NLTX annual total long term liabilities has changed by -$1.21 M (-10.27%)
What is Neoleukin Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of NLTX is $9.14 M
What is the all time high quarterly long term liabilities for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly total long term liabilities is $78.72 M
What is Neoleukin Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, NLTX quarterly total long term liabilities has changed by -$1.55 M (-14.52%)